Company intelligence / Profile preview

AGB-Pharma

Ownership: Private
Development stage: Commercial

Overview

AGB-Pharma manufactures and markets pharmaceuticals focused on sleep health. Their products have never been backordered in Sweden, indicating reliable production and supply chain management.[1]

Therapeutic areas: Neurology
Modalities: Pharmaceuticals for sleep disorders
Industry: Biotech

Drug pipeline

1 asset

Adaflex

Commercial

Indications: Insomnia in ADHD patients aged 6-17

Beyond the preview

Go deeper on AGB-Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGB-Pharma.

Explore the full profile